title: [Retractile mesenteritis. Diagnostic and therapeutic aspects].
abstract: An 18-year-old boy, who had severe abdominal pain for 18 months associated with marked weight loss, was found to have a stenosed ileal sling on double-contrast radiology of the small intestine. At operation a plate-like tumour was extending from the pancreas to the aortic bifurcation. Histological examination of removed tissue revealed retractile mesenteritis (mesenteric panniculitis; liposclerotic mesenteritis). The symptoms regressed and the patient again gained weight under immunotherapy with 1 mg/kg of prednisone and 2 mg/kg of cyclophosphamide daily. Subsequently, under prednisone alone, there was a recurrence, which responded within five weeks to daily 60 mg prednisone and 125 mg cyclophosphamide. The patient remains symptom-free on 125 mg cyclophosphamide and 10 mg prednisone daily.
authors.affiliation: Medizinische Klinik und Poliklinik, Universität Mainz.
authors.forename: C
authors.initials: C
authors.lastname: Trautwein
authors.forename: E
authors.initials: E
authors.lastname: Hermann
authors.forename: A
authors.initials: A
authors.lastname: Rambow
authors.forename: H
authors.initials: H
authors.lastname: Löhr
authors.forename: P
authors.initials: P
authors.lastname: Klose
authors.forename: H
authors.initials: H
authors.lastname: Gabbert
authors.forename: T
authors.initials: T
authors.lastname: Poralla
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000293:Adolescent; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D006801:Humans; D007421:Intestine, Small / Q000000981:diagnostic imaging; D008297:Male; D008643:Mesentery / Q000473:pathology; D015436:Panniculitis, Peritoneal / Q000175:diagnosis* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use*; D012008:Recurrence; D014057:Tomography, X-Ray Computed; D015431:Weight Loss
chemical_list: D003520:Cyclophosphamide; D011239:Prednisolone
vernacular_title: Die retraktile Mesenteritis. Diagnostische und therapeutische Aspekte.